Inhibition of lipid synthase activity: AOD 9604 reduces the activities of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC), and decreases de novo synthesis of fatty acids
To date, all these peptides have followed similar trajectories: promising animal data with no evidence of efficacy in humans, despite extensive advertising and widespread availability of these compounds to athletes, Ellis and colleagues wrote in their AOSSM article
Supporting gut health can dramatically improve mood, sleep, and emotional well-being
The Long-Term Timeline: 2 to 3 Months and Beyond The most lasting benefits are structural and take time, especially where the nervous system is concerned
As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity